Bruno Sainz

30PUBLICATIONS
107CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 07, 2026
Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells.

|Jun 01, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

|Dec 02, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou

|Aug 06, 2025
TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and metastasis.

Donatella Delle Cave, Annalisa Di Domenico, Marco Fantuz

|Jul 03, 2025
PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer.

Beatriz Parejo-Alonso, David Barneda, Sara Maria David Trabulo

|Feb 20, 2025
c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activation.

D Bakırdöğen, K Görgülü, J Xin

Pageof 5

Frequent Collaborators

4 joint publications

Sonia Alcalá

4 joint publications

Juan Carlos López-Gil

4 joint publications

Alfredo Carrato

4 joint publications

Patrick C Hermann